Global ADVENT FORUM 2023, Dermatology Plenary 3: Updates in PN and CSU: Emerging Therapeutic Landscapes and Implications for Patient Management
A review of disease burden and treatment needs in PN and CSU, and how current and emerging therapies can impact patient management in these respective diseases.
On demand materials
Learning objectives
- Describe the wide-ranging disease burden of PN and CSU, and discuss how this impacts patient quality of life and treatment needs
- Review current unmet needs in PN and CSU management
- Describe the evolving therapeutic landscape in PN and CSU, considering data for approved treatments and ongoing clinical trials, and discuss potential impacts on patient management in the respective therapeutic areas
Description
In this ADVENT symposium at the 2023 ADVENT FORUM, “Emerging Therapeutic Landscape and Implications for Patient Management in Prurigo Nodularis and Chronic Spontaneous Urticaria”, Raj Chovatiya, MD, PhD (George Washington University School of Medicine and Health Sciences, Washington DC, USA) and Thomas B. Casale, MD (University of South Florida, USA) reviewed the wide-ranging burden and unmet needs in PN and CSU, presented trial data for approved and emerging therapies, and discussed the implications of the evolving therapeutic landscape for patient management in both therapeutic areas.
About these experts
